mephenesin has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
Mephenesin: A centrally acting muscle relaxant with a short duration of action.
1-(2-methylphenyl)glycerol : A glycerol ether in which a single 2-methylphenyl group is attached at position 1 of glycerol via an ether linkage.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BARNARD, RD | 1 |
1 other study available for mephenesin and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Rectal administration of tolserol the therapeutic efficacy of this route as demonstrated in amyotrophic lateral sclerosis.
Topics: Administration, Rectal; Amyotrophic Lateral Sclerosis; Humans; Mephenesin; Sclerosis | 1949 |